Clinical Trial Update: Study of Combination Therapy With SYR-322 [Phase 3]

View source ↗

Summary

Takeda-sponsored Phase 3 trial evaluating a combination therapy with SYR-322 for diabetes mellitus has completed. The update notes completion but does not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SYR-322

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED